Next Article in Journal
Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
Previous Article in Journal
Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases
Previous Article in Special Issue
Impact of Post-Thaw Enrichment of Primary Human Hepatocytes on Steatosis, Inflammation, and Fibrosis in the TruVivo® System
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(1), 113; https://doi.org/10.3390/ph18010113
Action Date Notes Link
article xml file uploaded 16 January 2025 14:24 CET Original file -
article xml uploaded. 16 January 2025 14:24 CET Update -
article pdf uploaded. 16 January 2025 14:24 CET Version of Record -
article html file updated 16 January 2025 14:25 CET Original file -
article xml file uploaded 16 January 2025 14:51 CET Update -
article xml uploaded. 16 January 2025 14:51 CET Update https://www.mdpi.com/1424-8247/18/1/113/xml
article pdf uploaded. 16 January 2025 14:51 CET Updated version of record https://www.mdpi.com/1424-8247/18/1/113/pdf
article html file updated 16 January 2025 14:55 CET Update https://www.mdpi.com/1424-8247/18/1/113/html
Back to TopTop